Cargando…
Long-term recurrence-free survival in a patient with stage IVB uterine carcinosarcoma
Uterine carcinosarcomas are rare and highly aggressive tumors with a poor prognosis. Due to early metastasis and disease progression, it is known to be far more aggressive than matched grade 3 endometroid endometrial carcinomas. Five-year survival for stage IV is reported to be 10% and overall survi...
Autores principales: | Yoon, Gun, Kim, Yong-Seok, Kim, Byoung-Gie, Bae, Duk-Soo, Lee, Jeong-Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Gynecologic Oncology and Colposcopy
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3254849/ https://www.ncbi.nlm.nih.gov/pubmed/22247807 http://dx.doi.org/10.3802/jgo.2011.22.4.292 |
Ejemplares similares
-
Which is worse: uterine papillary serous carcinomas or carcinosarcomas?
por: Song, Taejong, et al.
Publicado: (2011) -
Prognostic factors for recurrence and survival in uterine leiomyosarcoma: Korean single center experience with 50 cases
por: Paik, E Sun, et al.
Publicado: (2019) -
Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer
por: Aoki, Yoichi, et al.
Publicado: (2018) -
Pulmonary metastasectomy in uterine malignancy: outcomes and prognostic factors
por: Paik, E Sun, et al.
Publicado: (2015) -
A comparison of uterine papillary serous, clear cell carcinomas, and grade 3 endometrioid corpus cancers using 2009 FIGO staging system
por: Kim, Ha-Jeong, et al.
Publicado: (2013)